Comparing two treatments for knee osteoarthritis
Official title: Efficacy of Genicular Artery Embolization Compared to Sensory Deinnervation for the Treatment of Symptomatic Knee Osteoarthritis: a Randomized Controlled Trial
Run by Queen's University · NCT06166628 · Data updated 2026-11-12
This study is testing two different treatments for knee osteoarthritis to see if they can help people with knee pain feel better compared to a fake procedure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Queen's University Academic / other |
| Locations | 1 site (Kingston, Ontario) |
| Status | Recruiting |
| Started | December 1, 2023 |
| Main results expected | December 1, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | December 28, 2023 |
| Trial ID | NCT06166628 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals over 40 years old with knee osteoarthritis pain that has not improved with conservative therapies for at least three months.
✕Probably not a fit
Patients with systemic inflammatory diseases, current infections, or contraindications for MR imaging may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of genicular artery embolization (GAE) and genicular nerve phenol nerve ablation (PNA) in alleviating symptoms of knee osteoarthritis (OA) compared to a sham procedure. It is a three-arm randomized controlled trial involving 150 participants who have experienced knee pain for at least six months and have not responded to conservative treatments. Participants will be assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and a numerical rating scale for pain at multiple time points. Additionally, the study aims to identify biomarkers that may predict treatment response.
Why it matters
Potential benefit: If successful, this study could provide new, effective treatment options for patients suffering from chronic knee osteoarthritis pain.
How similar studies have gone: While GAE and nerve ablation have shown promise in preliminary studies, this is one of the first randomized controlled trials directly comparing these two interventions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 40 years * Able to provide informed consent * Knee pain due to osteoarthritis for at least 6 months * Pain refractory to conservative therapies (oral medication, or physical therapy, or activity modification) for at least 3 months with a desire for TKA * Candidate for TKA at Hotel Dieu Hospital Site * Able to comply with all treatments and protocol follow-up visits Exclusion Criteria: * Current local infection * Systemic or joint centered inflammatory disease (ie rheumatoid arthritis, Lupus, multiple sclerosis or other autoimmune diseases) * Current use of systemic immunosuppression therapy * Known lower extremity vascular disease or lower extremity symptoms thought to be secondary to arterial vascular disease (eg claudication, ischemic rest pain) * Irreversible coagulopathy * Renal dysfunction as defined by GFR (eGFR) of \<30 obtained within the past 60 days * Contraindication for MR Imaging (such as claustrophobia, metallic fragment or foreign bones, implants or prosthesis) * IV CT and/or MRI contrast allergy characterized by anaphylaxis or anaphylactoid reactions * Pregnancy or women of childbearing potential not currently on a medically acceptable method of birth control
Where it's running
-
Kingston Health Sciences Centre
Kingston, Ontario, Canada Recruiting
Study contacts
- Principal investigator: David Clinkard, MD — Queen's University
- Study coordinator: David Clinkard, MD
- Email: david.clinkard@kingstonhsc.ca
- Phone: 613-549-6666
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Effects of virtual reality on walking in adults with knee osteoarthritis
This study tests how immersive virtual reality environments—designed to feel safe or to provoke fear—affect walking and worry about movement in adults 50 and older with knee osteoarthritis and in healthy peers.
-
Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese
This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
Preoperative Multimorbidity and Functional Recovery After Total Knee Arthroplasty
This study tests whether higher burden of preoperative multimorbidity affects functional recovery after knee replacement in adults with knee osteoarthritis.
-
Cartilage biomarker response to acute loading in knee OA by antiresorptive treatment status
Researchers will test whether a 30-minute treadmill walk changes cartilage biomarkers in postmenopausal women with knee osteoarthritis, comparing those on denosumab, bisphosphonates, and those not on antiresorptives.
-
Lysyl Enzymes in Knee Osteoarthritis
This study tests whether blood levels of lysyl hydroxylase and lysyl oxidase differ between people with knee osteoarthritis and healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.